NCT00003593 arm group 381474a769538531e2d344a1a65b0f2f [clinicaltrials_resource:NCT00003593/arm-group/381474a769538531e2d344a1a65b0f2f]
asparaginase [clinicaltrials_resource:22cbb4cee92bf7c54fe0e1de3438429b]cytarabine [clinicaltrials_resource:4b8172df6997166a977e08b390b4f0fa]therapeutic hydrocortisone [clinicaltrials_resource:6f1bfb5455cf5e356d1629b185cab940]daunorubicin hydrochloride [clinicaltrials_resource:81fadcf49cea67a08bdb074ed31ea5a2]thioguanine [clinicaltrials_resource:d5cb4ca7345d9fc0cf1d25bab3c607ea]methotrexate [clinicaltrials_resource:d66c9c8c7cada93742b779e81bd8ad94]clinicaltrials:NCT00003593
arm group [clinicaltrials_vocabulary:arm-group]
NCT00003593 arm group 381474a769538531e2d344a1a65b0f2f [clinicaltrials_resource:NCT00003593/arm-group/381474a769538531e2d344a1a65b0f2f]
Bio2RDF identifier
NCT00003593/arm-group/381474a769538531e2d344a1a65b0f2f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 1474a769538531e2d344a1a65b0f2f
description [clinicaltrials_vocabulary:description]
(closed to accrual as of 6/24/ ...... tensification 1 day 1 hour 18.
identifier
clinicaltrials_resource:NCT00003593/arm-group/381474a769538531e2d344a1a65b0f2f
title
NCT00003593 arm group 381474a769538531e2d344a1a65b0f2f
@en
type
label
NCT00003593 arm group 381474a7 ...... 474a769538531e2d344a1a65b0f2f]
@en